Laura D. Healy

586 total citations
15 papers, 442 citations indexed

About

Laura D. Healy is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Laura D. Healy has authored 15 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Laura D. Healy's work include Platelet Disorders and Treatments (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Laura D. Healy is often cited by papers focused on Platelet Disorders and Treatments (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Laura D. Healy collaborates with scholars based in United States, Australia and Japan. Laura D. Healy's co-authors include Owen J. T. McCarty, András Gruber, Joseph E. Aslan, Rachel A. Rigg, John H. Griffin, Jiaqing Pang, Cassandra P. Loren, José A. Fernández, Monica T. Hinds and Cristina Puy and has published in prestigious journals such as Journal of Biological Chemistry, American Journal of Physiology-Cell Physiology and Journal of Leukocyte Biology.

In The Last Decade

Laura D. Healy

15 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura D. Healy United States 12 217 132 123 95 62 15 442
Eveline A. M. Bouwens Netherlands 9 315 1.5× 93 0.7× 110 0.9× 86 0.9× 66 1.1× 11 473
Sylvie Daliphard France 12 197 0.9× 118 0.9× 88 0.7× 160 1.7× 26 0.4× 27 489
Céline Bouvy Belgium 13 147 0.7× 49 0.4× 153 1.2× 57 0.6× 54 0.9× 30 421
Winifred Trotman United States 12 115 0.5× 50 0.4× 170 1.4× 40 0.4× 32 0.5× 18 546
Sean Lang Canada 9 291 1.3× 84 0.6× 52 0.4× 19 0.2× 68 1.1× 9 450
Jana Procházková Czechia 12 66 0.3× 109 0.8× 99 0.8× 98 1.0× 25 0.4× 25 384
Luis Ramón Spain 17 98 0.5× 262 2.0× 208 1.7× 45 0.5× 38 0.6× 31 885
Daniel L. Sprague United States 6 172 0.8× 142 1.1× 147 1.2× 21 0.2× 23 0.4× 7 467
Halina Leung Australia 10 189 0.9× 300 2.3× 189 1.5× 19 0.2× 32 0.5× 14 608
Kishiko Nakamura Japan 13 123 0.6× 107 0.8× 118 1.0× 43 0.5× 24 0.4× 18 440

Countries citing papers authored by Laura D. Healy

Since Specialization
Citations

This map shows the geographic impact of Laura D. Healy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura D. Healy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura D. Healy more than expected).

Fields of papers citing papers by Laura D. Healy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura D. Healy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura D. Healy. The network helps show where Laura D. Healy may publish in the future.

Co-authorship network of co-authors of Laura D. Healy

This figure shows the co-authorship network connecting the top 25 collaborators of Laura D. Healy. A scholar is included among the top collaborators of Laura D. Healy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura D. Healy. Laura D. Healy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Healy, Laura D., Erik I. Tucker, David Gailani, et al.. (2023). Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice. Metabolic Brain Disease. 38(7). 2383–2391. 6 indexed citations
2.
Healy, Laura D., José A. Fernández, Laurent O. Mosnier, & John H. Griffin. (2020). Activated protein C and PAR1‐derived and PAR3‐derived peptides are anti‐inflammatory by suppressing macrophage NLRP3 inflammasomes. Journal of Thrombosis and Haemostasis. 19(1). 269–280. 16 indexed citations
3.
Shirai, Toshiaki, Alexey S. Revenko, Justin Tibbitts, et al.. (2019). Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice. Blood Advances. 3(20). 3080–3091. 23 indexed citations
4.
Chiovaro, Joseph, Laura D. Healy, Michele Freeman, et al.. (2018). Antithrombotic Strategies After Bioprosthetic Aortic Valve Replacement: A Systematic Review. The Annals of Thoracic Surgery. 107(5). 1571–1581. 4 indexed citations
5.
Rigg, Rachel A., Laura D. Healy, Anh T. P. Ngo, et al.. (2018). Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions. Platelets. 30(1). 126–135. 29 indexed citations
6.
Healy, Laura D., Rachel A. Rigg, John H. Griffin, & Owen J. T. McCarty. (2018). Regulation of immune cell signaling by activated protein C. Journal of Leukocyte Biology. 103(6). 1197–1203. 16 indexed citations
7.
Healy, Laura D., Cristina Puy, José A. Fernández, et al.. (2017). Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo. Journal of Biological Chemistry. 292(21). 8616–8629. 94 indexed citations
8.
Rigg, Rachel A., Laura D. Healy, Jérémy Mallet, et al.. (2016). Heat shock protein 70 regulates platelet integrin activation, granule secretion and aggregation. American Journal of Physiology-Cell Physiology. 310(7). C568–C575. 28 indexed citations
9.
Healy, Laura D., Cristina Puy, Asako Itakura, et al.. (2016). Colocalization of neutrophils, extracellular DNA and coagulation factors during NETosis: Development and utility of an immunofluorescence-based microscopy platform. Journal of Immunological Methods. 435. 77–84. 29 indexed citations
10.
Phillips, Kevin G., Laura D. Healy, Asako Itakura, et al.. (2015). Critical Behavior of Subcellular Density Organization During Neutrophil Activation and Migration. Cellular and Molecular Bioengineering. 8(4). 543–552. 1 indexed citations
11.
Rigg, Rachel A., Joseph E. Aslan, Laura D. Healy, et al.. (2015). Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function. American Journal of Physiology-Cell Physiology. 310(5). C373–C380. 57 indexed citations
12.
Verbout, Norah G., Xiaolin Yu, Laura D. Healy, et al.. (2014). Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis. Metabolic Brain Disease. 30(1). 57–65. 16 indexed citations
13.
Loren, Cassandra P., Joseph E. Aslan, Rachel A. Rigg, et al.. (2014). The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear. Thrombosis Research. 135(1). 155–160. 67 indexed citations
14.
Jones, Casey M., Laura D. Healy, Jonathan W. Nelson, et al.. (2013). Measurement Science in the Circulatory System. Cellular and Molecular Bioengineering. 7(1). 1–14. 23 indexed citations
15.
Aslan, Joseph E., Kevin Phillips, Laura D. Healy, et al.. (2013). Histone deacetylase 6-mediated deacetylation of α-tubulin coordinates cytoskeletal and signaling events during platelet activation. American Journal of Physiology-Cell Physiology. 305(12). C1230–C1239. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026